| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19402285
[patent_doc_number] => 20240285796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => CATIONIC LIPIDS AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/612564
[patent_app_country] => US
[patent_app_date] => 2024-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/612564 | Lipids and compositions thereof | Mar 20, 2024 | Issued |
Array
(
[id] => 19503835
[patent_doc_number] => 12115233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Imaging and radiotherapeutics agents targeting fibroblast-activation protein-a (FAP-a)
[patent_app_type] => utility
[patent_app_number] => 18/585905
[patent_app_country] => US
[patent_app_date] => 2024-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 17963
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18585905
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/585905 | Imaging and radiotherapeutics agents targeting fibroblast-activation protein-a (FAP-a) | Feb 22, 2024 | Issued |
Array
(
[id] => 19216132
[patent_doc_number] => 20240180836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/410875
[patent_app_country] => US
[patent_app_date] => 2024-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18410875
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/410875 | Cationic Lipid Compound and Composition for Delivery of Nucleic Acids and Use Thereof | Jan 10, 2024 | Abandoned |
Array
(
[id] => 19359189
[patent_doc_number] => 20240261223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => MODULAR LIPID COMPOUNDS AND TWO- TO THREE-COMPONENT LIPID NANOPARTICLE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/396075
[patent_app_country] => US
[patent_app_date] => 2023-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18396075
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/396075 | MODULAR LIPID COMPOUNDS AND TWO- TO THREE-COMPONENT LIPID NANOPARTICLE COMPOSITIONS | Dec 25, 2023 | Pending |
Array
(
[id] => 19440000
[patent_doc_number] => 12090227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Method to improve the encapsulation efficiency and physicochemical stability of ginsenosides Rg3 and CK nano-emulsion
[patent_app_type] => utility
[patent_app_number] => 18/526168
[patent_app_country] => US
[patent_app_date] => 2023-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 19
[patent_no_of_words] => 9979
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18526168
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/526168 | Method to improve the encapsulation efficiency and physicochemical stability of ginsenosides Rg3 and CK nano-emulsion | Nov 30, 2023 | Issued |
Array
(
[id] => 19111349
[patent_doc_number] => 20240123099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => RADIOLABELED COMPOUNDS FOR IN VIVO IMAGING OF GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR) AND TREATMENT OF GRPR-RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/512708
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/512708 | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders | Nov 16, 2023 | Issued |
Array
(
[id] => 19201541
[patent_doc_number] => 20240173440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/477504
[patent_app_country] => US
[patent_app_date] => 2023-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18477504
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/477504 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | Sep 27, 2023 | Pending |
Array
(
[id] => 19125850
[patent_doc_number] => 20240131203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => FIBROBLAST ACTIVATION PROTEIN (FAP) INHIBITORS, FAP CONJUGATES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/474209
[patent_app_country] => US
[patent_app_date] => 2023-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474209
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/474209 | Fibroblast activation protein (FAP) inhibitors, FAP conjugates, and diagnostic and therapeutic uses thereof | Sep 24, 2023 | Issued |
Array
(
[id] => 19246942
[patent_doc_number] => 20240197926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => METHOD OF TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/448609
[patent_app_country] => US
[patent_app_date] => 2023-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18448609
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/448609 | METHOD OF TREATING PROSTATE CANCER | Aug 10, 2023 | Abandoned |
Array
(
[id] => 19059007
[patent_doc_number] => 11938201
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha)
[patent_app_type] => utility
[patent_app_number] => 18/354282
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 17941
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18354282
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/354282 | Imaging and radiotherapeutics agents targeting fibroblast-activation protein-alpha (FAP-alpha) | Jul 17, 2023 | Issued |
Array
(
[id] => 18707692
[patent_doc_number] => 20230330274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/320890
[patent_app_country] => US
[patent_app_date] => 2023-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18320890
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/320890 | METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS | May 18, 2023 | Pending |
Array
(
[id] => 18510125
[patent_doc_number] => 20230226226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => MULTI-SIGNAL FLUORESCENT PROBE FOR EARLY DIAGNOSIS OF TUMORS, AND PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/189238
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18189238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/189238 | Multi-signal fluorescent probe for early diagnosis of tumors, and preparation and use thereof | Mar 23, 2023 | Issued |
Array
(
[id] => 18581657
[patent_doc_number] => 20230263911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => COMPOSITIONS INCLUDING PAFOLACIANINE FOR THE IDENTIFICATION OF MALIGNANT LESIONS
[patent_app_type] => utility
[patent_app_number] => 18/111704
[patent_app_country] => US
[patent_app_date] => 2023-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111704
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/111704 | Compositions including pafolacianine for the identification of malignant lesions | Feb 19, 2023 | Issued |
Array
(
[id] => 19410650
[patent_doc_number] => 12076443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Preparation method of nanozyme composite-based hybrid hydrogel eye drop
[patent_app_type] => utility
[patent_app_number] => 18/572198
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 2179
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572198 | Preparation method of nanozyme composite-based hybrid hydrogel eye drop | Feb 14, 2023 | Issued |
Array
(
[id] => 18308553
[patent_doc_number] => 20230112453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHODS AND MATERIALS FOR TREATING HYPOCAPNIA
[patent_app_type] => utility
[patent_app_number] => 18/080346
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080346
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080346 | METHODS AND MATERIALS FOR TREATING HYPOCAPNIA | Dec 12, 2022 | Pending |
Array
(
[id] => 19125852
[patent_doc_number] => 20240131205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => DUAL-TARGETING COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/546989
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546989 | Dual-targeting compound and preparation method and application thereof | Dec 8, 2022 | Issued |
Array
(
[id] => 18449716
[patent_doc_number] => 20230190992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => HEMOSTATIC MATERIAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/062577
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062577
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062577 | HEMOSTATIC MATERIAL COMPOSITION | Dec 6, 2022 | Pending |
Array
(
[id] => 18383221
[patent_doc_number] => 11653984
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-23
[patent_title] => Unassisted robotic surgery employing paramagnetic halo metallofullerenes as minimally invasive, precision scalpels or micronization particles through magnetic field manipulation and targeted exenteration patterned by programmed 3D imaging using needle or magnetic energy access and microelectronic semiconducting in non-stationary wafer-less space
[patent_app_type] => utility
[patent_app_number] => 17/884185
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 7188
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884185
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/884185 | Unassisted robotic surgery employing paramagnetic halo metallofullerenes as minimally invasive, precision scalpels or micronization particles through magnetic field manipulation and targeted exenteration patterned by programmed 3D imaging using needle or magnetic energy access and microelectronic semiconducting in non-stationary wafer-less space | Aug 8, 2022 | Issued |
Array
(
[id] => 19915230
[patent_doc_number] => 12290576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Manufacturing of dimeric contrast agents
[patent_app_type] => utility
[patent_app_number] => 18/565770
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9878
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/565770 | Manufacturing of dimeric contrast agents | Jul 25, 2022 | Issued |
Array
(
[id] => 18147202
[patent_doc_number] => 20230021059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHODS OF FUNCTIONALIZING NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/867030
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17867030
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/867030 | METHODS OF FUNCTIONALIZING NANOPARTICLES | Jul 17, 2022 | Abandoned |